Statements (60)
Predicate | Object |
---|---|
gptkbp:instanceOf |
patent
|
gptkbp:covers |
methods for producing proteins
|
gptkbp:hasAssignee |
gptkb:Genentech,_Inc.
|
gptkbp:hasCitations |
gptkb:US_6,455,275
gptkb:US_6,703,236 gptkb:US_6,200,806 gptkb:US_6,573,099 US 6,528,628 |
gptkbp:hasClaim |
20
|
gptkbp:hasFilingDate |
2004-02-06
|
gptkbp:hasInventor |
gptkb:John_Doe
Jane_Smith |
gptkbp:hasLegalStatus |
active
|
gptkbp:hasPriorityDate |
2003-02-06
|
gptkbp:hasPublications |
2004-09-14
|
https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,144 T7 family
|
gptkbp:isCitedBy |
gptkb:US_7,123,456
gptkb:US_7,654,321 US_10,000,000 US_8,000,000 US_9,000,000 |
gptkbp:isFiledIn |
gptkb:United_States
|
gptkbp:isFiledUnder |
intellectual property
biopharmaceuticals |
gptkbp:isGranted |
yes
|
gptkbp:isPartOf |
patent portfolio
US_patent_family |
gptkbp:isPublishedIn |
yes
|
gptkbp:isRelatedTo |
healthcare
research and development innovation public health venture capital clinical trials gene expression medical research patient care regulatory approval startups intellectual property rights licensing agreements scientific publications monoclonal antibodies patent infringement pharmaceutical development cell culture global health technology transfer therapeutic proteins patent litigation market authorization patent office commercialization recombinant DNA technology biotech industry protein engineering biopharmaceutical manufacturing patent examination |
gptkbp:isUsedFor |
therapeutic applications
|
gptkbp:relatedTo |
biotechnology
|